A pilot study of young adults with multiple sclerosis: Demographic, disease, treatment, and psychosocial characteristics
published online 30 November 2009. Corrected Proof
Abstract
Background
Although multiple sclerosis (MS) is the most common neurologic disease disabling younger adults, very little is known about the characteristics of young adults with MS and the impact of MS on their lives.
Objectives
To conduct a pilot study of the demographic, disease, treatment, and psychosocial characteristics of young adults with MS (aged 18 and 31 years).
Methods
We solicited participation from all 452 members of the Registry of the North American Research Committee On Multiple Sclerosis (NARCOMS) Project aged 18 to 31 years, collecting data from 100 of these young adults (22%) by computer-assisted telephone interviews. Data included basic demographic, disease, and treatment characteristics, ratings of satisfaction with access to and quality of MS and mental health care, and beliefs about the impact of MS on their current and future lives.
Results
Participants were 93% female and averaged 28.6 years of age, and 88% had relapsing-remitting MS. Forty-three percent received the majority of their MS-focused care at an MS clinic and 94% had seen a neurologist in the previous 12 months. More than 40% reported depressive symptoms at the time of the survey. These young adults with MS had relatively low rates of concern about the impact of MS in the present but higher rates of worry about their future.
Conclusions
These findings suggest the need for a study with a larger, representative sample of young adults with MS to guide development of programs, interventions, and services tailored to meet their needs.
aDepartment of Political Science and Public Administration, Mississippi State University, Mississippi State, MS 39762, USA
bDepartment of Psychiatry, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA
cDepartment of Health Care Administration and Health Sciences, Tennessee State University, Nashville, TN 37203, USA
dNARCOMS, Barrow Neurological Institute, Phoenix, AZ 85013, USA
eDivision of Neurology, Barrow Neurological Institute, Phoenix, AZ 85013, USA
Corresponding author: P. O. Box PC. Fax: (662) 325-2716.
Financial disclosure: This research was supported by a Pilot Research Award from the National Multiple Sclerosis Society (PP 1349). The authors have no conflicts of interest to declare.
ABSTRACT